Cloud DX Inc
OTC:CDXFF
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Cloud DX Inc
Research & Development
Cloud DX Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Cloud DX Inc
OTC:CDXFF
|
Research & Development
-CA$193k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Covalon Technologies Ltd
XTSX:COV
|
Research & Development
-CA$1.2m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-8%
|
|
|
I
|
Imaging Dynamics Co Ltd
XTSX:IDL
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Aurora Spine Corp
XTSX:ASG
|
Research & Development
-$764.5k
|
CAGR 3-Years
7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-25%
|
|
|
N
|
NuGen Medical Devices Inc
XTSX:NGMD
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
O
|
Ondine Biomedical Inc
LSE:OBI
|
Research & Development
-CA$9.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cloud DX Inc
Glance View
Cloud DX, Inc. provides remote patient monitoring hardware and software. The company is headquartered in Calgary, Alberta. The company went IPO on 2019-08-19. The firm provides remote patient monitoring hardware, software and recurring revenue services in a transaction model, coupled with a sales strategy for healthcare providers. The Cloud DX Connected Health platform includes Clinician Portal that streamlines the workflow required to provide Remote Patient Monitoring (RPM) and Telemedicine (TM). The Connected Health mobile application includes an optional Telemedicine feature powered by Zoom and available for Android and iOS devices. Its feature allows for privacy-compliant video consultations directly for the Cloud DX app to the clinician's portal. The Company’s Pulsewave Health Monitor is a multi-function virtual medical device and Cloud Diagnostics software application which measures heart rate, blood pressure and cardiac anomalies in real time.
See Also
What is Cloud DX Inc's Research & Development?
Research & Development
-193k
CAD
Based on the financial report for Dec 31, 2023, Cloud DX Inc's Research & Development amounts to -193k CAD.
What is Cloud DX Inc's Research & Development growth rate?
Research & Development CAGR 1Y
51%
Over the last year, the Research & Development growth was 51%.